Game changing x-ray imaging applications!
Vision for Better Imaging!
Innomentarium is privately owned Finnish health-tech company that was established in 2010, business activities initiated in 2014. Even though we are a young company, we have decades of experience in the health-tech business and medical imaging. We have harnessed the knowhow to research and develop new ways of imaging to create high-quality and affordable solutions for different imaging applications, especially for segmentation of the smallest biological details from the objects being imaged, like human soft tissues and seeds. The company is based in Finland, hi-tech city of Oulu by the Gulf of Botnia, 660 km/one hour flight up to north from Helsinki, the capital of Finland, 200 km south from the arctic circle.
The Core Team
Jouni Ihme, Bsc, eng.
CEO, founder
1989 – 1993
Instrumentarium Oyj
1994 – 2013 Innokas Medical Oy
2014 – Innomentarium Oy
Raija Kilponen, Radiographer, BSc (ICT)
Product manager, Medical Imaging
2002 – 2012 Nokia Mobile Phones
2013 – 2017 University of Applied Sciences
2017 – Innomentarium Oy
Angelos Fylakis, D.Sc. (Tech)
Head of Research and development
2018 – 2022 Mikronix Oy
2022 – Innomentarium Oy
Aleksi Yrttiaho, M.Sc (Tech) in Biomedical Engineering).
Software developer
2022 – 2023 Mikronix Oy
2024 – Innomentarium Oy
Board of Directors
Jouni Ihme – CEO, Chairman
Background: Instrumentarium Corp. Datex Div., Founder of Innokas Medical 1994-2013
Jouni Pohjonen
Background: Instrumentarium Corp., Perlos Healthcare, Yhdistyneet Medix laboratoriot, Korona Invest
Juha Puutio
Legal, M&A arrangements
Olli Silven
Background in machine vision research at the University of Oulu, University of Maryland, and Yokohama National University
Quality Policy
With our products we fulfill all the quality requirements and regulative demands according to international standards.
We are committed to give the best service to our customers and always exceed their expectations.
Vision and Mission
Vision
Our vision is to create new innovations into x-ray imaging to detect defects and diseases for preventive and corrective actions. For the health of earth and human being.Mission
Our mission is to research, develop and produce qualified and affordable imaging solutions based on long term expertise in x-ray imaging using the newest state of the art image processing, machine vision and artificial intelligent methods and technologies. We have committed to maintain and support our products in long term relationships with the customers.
Our Values
The business is based on long-term strategy and strong values as follows.
Care
We take good care of our team and our customers in all situations, especially when things do not go as planned. This can be seen in daily operations as a good team spirit, flexible service and happy customers.
Transparency
Maintaining open and transparent communication with organizations, customers, stakeholders, and owners— regularly and in all circumstances.
Sustainability
Sustainable and profitable operations that make it possible to invest in the future and provide a reasonable annual return on investment to the company’s shareholders.
Entrepreneurship
Strong entrepreneurship and open, independent ownership enable long-term investments in research and development of operations, products and services.
Compliance
We comply with corporate governance, good accounting practices, and laws while respecting our customers, employees, and shareholders.
How It All Started
History
Innomentarium is a health technology company that was originally founded by Jouni Ihme in March 2008. In the inital phase, it functioned as a holding company during his former company’s Innokas Medical ownership restructuring at that time.
“Innokas Medical is the company I established in 1994 and run 20 years having 23M€ revenue and 200 healthtech professionals when I left the company. In 2008 we had a challenging situaton to rearrange the ownership of the company. Actually Innomentarium was established in the forest, in the middle of nowhere in Sarajärvi where I was born. While doing forest work, I was thinking the way to find out the solution in the situation, for the best of the company and its staff’s future. So, originally Innomentarium was born in the tight circumstances to survival. I’m sure it will be seen in the company’s future when we are building our story, as a persistence and innovativeness. In 2010 the holding company’s name was changed to Innokas Yhtymä, officially Innokas Group in English. At the time I wanted to protect the Innomentarium name, so a new company was founded, which became our current Innomentarium,” explains the company’s founder, Jouni Ihme.
“Big changes in my life happened at the end of 2013 when I left Innokas. Long journey from start up to successful and international healthtech company had ended for me. Big changes in your life create also opportunities to do something new. So it made it possible to start to ramp up operations in Innonentarium at the beginning of 2014,” Ihme continues.
The company is built on decades of experience in the international health technology business and medical imaging expertise. “Our passionate goal is to bring additional quality into ordinary people’s lives using novel imaging technologies. In practice that enable better diagnoses and examinations of diseases that have a dramatic impact on people’s health. That can be done in close collaboration with top universities, clinical experts and together with our network of medical imaging professionals,” Ihme continues.
Jouni Ihme, CEO
Innomentarium roadmap since 2014
2014 – MedTech business consulting and advisory services established
2015 – 2017: Supreme Finnish inversion for X-ray imaging (SFINX). University of
Helsinki, Industrial Mathematics, Inverse Problems and 3D Tomosynthesis
Imaging, Prof. Samuli Siltanen. Project funded by Research Council of Finland.
2016 – 2019: Project Heart Beat. Technical and algorithmic approaches to medical
photon counting computed tomography of coronary artery calcium quantification.
University of Oulu, Faculty of Medicine, Prof. Miika Nieminen. Project funded
by TEKES (Business Finland).
2019 – Development of the FeniX mammography digitalization solution completed and
successfully introduced to the Finnish market, enabling digitalization of both
stationary and mobile installations
2020 – 2023: PoDoCo research project. An AI assisted approach for mammography image
quality assessment, processing and analysis. University of Oulu, Information
Technology, Prof. Tapio Seppänen. Project funded by Paulo Foundation.
2021 – Project to digitalize breast cancer specimen imaging cabinets launched in
collaboration with Turku University Hospital, branded later on as SpeciX
March 2024 – collaboration with Natural Resources of Finland (LUKE) for studying the seed
imaging for quality assessment using Innomentarium imaging platform, branded
later on as SeediX
2024 – Contrast Enhancement Method in Soft Tissues Segmentation in Medical
Applications, funded by POC fund of University of Oulu, Information Technology
ITEE, Prof. Tapio Seppänen. Published in EMPC European Medical Physicists conference
in Munich, Germany.
October 2024 – First installation of a mobile mammography X-ray clinic for breast
cancer screening successfully implemented, branded as MobiX
January 2025 – SpeciX system enters pilot clinical use
May 2025 – First installation of SeediX solution upgrading customer’s existing Faxitron
MX-20 x-ray cabinet
